A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11β hydroxysteroid dehydrogenase type 1 (11β HSD-1). We created transgenic mice overexpressing 11β HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11β HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [137]
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Self-citationThe Degree of Masculine Differentiation of Obesities
VAGUE, J. (1956) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/4.1.20 · Cited by 1,410
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 974
Research works printed but not linked: 5
- 10.1210/jcem.86.3.7453 · doi:10.1210/jcem.86.3.7453 · Paper page
- 10.1101/gad.7.7b.1318 · doi:10.1101/gad.7.7b.1318 · Paper page
- Supplementary data are available on Science Online at www.sciencemag.org/cgi/content/full/294/5549/2166/DC1.
- Strack A. M., Bradbury M. J., Dallman M. F., Am. J. Physiol. 268, R183 (1995).
- 10.1210/jcem.83.5.4951 · doi:10.1210/jcem.83.5.4951 · Paper page
Cited by
Items 201–300 of 1,003
Bujalska, I. J., Draper, N., Michailidou, Z., Tomlinson, J. W., White, P. C., Chapman, K. E., Walker, E. A., & Stewart, P. M. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01718 · Cited by 165
“In vivo and in intact cells, oxo-reductase activity predominates (Bujalska et al. 1997a, Jamieson et al. 2000, Masuzaki et al. 2001), but in cellular homogenates or in purified preparations, the enzyme behaves as a dehydrogenase (Lakshmi & Monder 1988); oxo-reductase activity can only be recovered…”
BackgroundThe Role of Aldosterone in Obesity-Related Hypertension
Kawarazaki, W., & Fujita, T. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw003 · Cited by 165
Moraes, R. C., Blondet, A., Birkenkamp-Demtroeder, K., Tirard, J., Orntoft, T. F., Gertler, A., Durand, P., Naville, D., & Bégeot, M. (2003) · Endocrinology · doi:10.1210/en.2003-0456 · Cited by 149
“This enzyme could not be primarily involved in the development of abdominal fat in this model of obesity, in contrast to the transgenic model, where visceral obesity was induced by overexpression of this enzyme selectively in adipose tissue (42).”
ResultMcCrindle, B. W., Mietus‐Snyder, M., Steinberger, J., Daniels, S. R., Eckel, R. H., & Hayman, L. L. (2009) · Cited by 165
Body composition assessment for the definition of cardiometabolic risk.
Amato, M. C., Guarnotta, V., & Giordano, C. S. D. S. (2014) · PubMed · doi:10.3275/8943 · Cited by 128
“In particular, the increase in visceral adipose tissue (VAT) is linked to insulin resistance, dyslipidemia, low grade inflammation, diabetes, hypertension and cardiovascular disease (2-14).”
BackgroundKoliwad, S. K., Kuo, T., Shipp, L. E., Gray, N. E., Backhed, F., So, A. Y.-L., Farese, R. V., & Wang, J.-C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025452 · Cited by 164
The contribution of animal models to the study of obesity
Speakman, J. R., Hambly, C., Mitchell, S. E., & Król, E. (2008) · Laboratory Animals · doi:10.1258/la.2007.006067 · Cited by 164
“Mice overexpressing 11b-HSD-1 (Masuzaki et al. 2001, Masuzaki & Flier 2003) displayed similar symptoms of the metabolic syndrome as seen in humans, i.e. visceral obesity, insulin and leptin resistance, dyslipidaemia and hypertension (Rask 2001), whereas mice with a null mutation in the 11b-HSD-1…”
Is Metabolic Syndrome X an Inflammatory Condition?
Das, U. N. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222701106 · Cited by 140
The influence of glucocorticoid signaling on tumor progression
Volden, P. A., & Conzen, S. D. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.022 · Cited by 163
“…overexpression of the gene encoding 11b-HSDI exhibit increased local corticosterone production and develop the metabolic syn drome, clearly demonstrating that a tissue-specific (rather than systemic) increase in active GCs can dramatically affect whole ani mal physiology (Masuzaki et al., 2001).”
InfluentialPlaisier, C. L., Horvath, S., Huertas-Vazquez, A., Cruz-Bautista, I., Herrera, M. F., Tusie-Luna, T., Aguilar-Salinas, C., & Pajukanta, P. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000642 · Cited by 163
“Studies in mice have also demonstrated that genetic manipulation of Abcc6 , Akt2 and Hsd11b1 affect FCHL component traits or related phenotypes [47–49].”
Morton, N. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 163
“On the other hand, adipokine release occurs more actively in visceral fat, where GR levels are higher (Pedersen et al., 1994; Masuzaki et al., 2001), suggesting 11 -HSD1 activity might primarily affect adipokine profiles in this depot.”
InfluentialSelf-citationInhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Wamil, M., & Seckl, J. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.001 · Cited by 163
Self-citationFryk, E., Olausson, J., Mossberg, K., Strindberg, L., Schmelz, M., Brogren, H., Gan, L., Piazza, S., Provenzani, A., Becattini, B., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103264 · Cited by 163
“…in both obese groups compared to Lean individuals: Early growth response 2 (EGR2) also known as Krox20 [44]; cartilage oligomeric matrix protein (COMP) [45]; WNT1 inducible signalling pathway protein 2 (WISP2) [46]; hydroxysteroid 11-beta dehydrogenase 1(HSD11B1) [47]; and apelin (APLN) [48] (Fig.”
BackgroundGlucocorticoids produce whole body insulin resistance with changes in cardiac metabolism
Qi, D., & Rodrigues, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00453.2006 · Cited by 162
“11 -HSD1 potentially contributes to obesity and insulin resistance in both rodents (103, 111) and humans (85, 98).”
BackgroundAndrogen metabolism in adipose tissue: Recent advances
Blouin, K., Veilleux, A., Luu-The, V., & Tchernof, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.035 · Cited by 160
Chen, X., Hussain, S., Parveen, S., Zhang, S., Yang, Y., & Zhu, C. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801323225 · Cited by 163
“The connection between 11- -HSD1 and T2D has been demonstrated in mouse genetic models [109, 115].”
BackgroundThe voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight
Xu, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.5.551 · Cited by 149
“For example, quantitative trait loci have been mapped using knockout/congenic strains (23) and mice transgenic mice over-expressing the enzyme 11B hydroxysteroid dehydrogenase type 1 are prone to developing visceral obesity, particularly when placed on a high-fat diet (24).”
BackgroundFloyd, Z. E., & Stephens, J. M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.308 · Cited by 137
“Transgenic mice overexpressing 11 -hydroxysteroid dehydrogenase type I selectively in adipose tissue exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and hyperphagia (31).”
Feig, P. U., Shah, S., Hermanowski‐Vosatka, A., Plotkin, D., Springer, M. S., Donahue, S., Thach, C., Klein, E. J., Lai, E., & Kaufman, K. D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01375.x · Cited by 161
“Additionally, mice in which the HSD1 gene was transgenically overexpressed in either adipose tissue or the liver exhibited a MetS-like phenotype (12).”
BackgroundThe glucocorticoid receptor: cause of or cure for obesity?
John, K., Marino, J. S., Sánchez, E. R., & Hinds, T. D. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00478.2015 · Cited by 162
Nakagawa, K., Kishida, H., Arai, N., Nishiyama, T., & Mae, T. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1775 · Cited by 136
Mechanisms of obesity and related pathology: linking immune responses to metabolic stress
Karalis, K. P., Giannogonas, P., Kodela, E., Koutmani, Y., Zoumakis, M., & Teli, T. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07304.x · Cited by 160
Valsamakis, G., Anwar, A., Tomlinson, J. W., Shackleton, C. H. L., McTernan, P. G., Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032240 · Cited by 160
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
“The importance of VAT glucocorticoid metabolism by 11-bHSD type 1 is demonstrated in experimental animals overexpressing 11-bHSD in all adipose tissues [62].”
BackgroundGuo, X., Li, J., Tang, R., Zhang, G., Zeng, H., Wood, R. J., & Liu, Z. (2017) · Mediators of Inflammation · doi:10.1155/2017/9474896 · Cited by 159
“This 60% kcal HF (with the control 10% kcal LF diet) is widely used for diet-induced obesity [20, 21].”
MethodYang, K., Guan, H., Arany, E., Hill, D. J., & Cao, X. (2008) · The FASEB Journal · doi:10.1096/fj.07-100735 · Cited by 159
“model was glucocorticoid dependent, because of a recently established link between elevated adipose tissue glucocorticoid activity and visceral obesity (40).”
BackgroundInfluentialUsing mouse models to dissect the genetics of obesity
Brockmann, G. A., & Bevova, M. R. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02703-8 · Cited by 159
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 137
“Many previous animal studies have shown that the administration of an inhibitor of 11 -hydroxysteroid dehydrogenase (11 -HSD) type I, or genetic deficiency of 11 -HSD type I, ameliorated insulin resistance (3, 158, 173), whereas adipose specific overexpression of 11 -HSD type I produced a phenotype remarkably similar…”
Background11&Bgr;-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Morton, N. M., & Seckl, J. R. (2008) · Frontiers of Hormone Research · doi:10.1159/000115363 · Cited by 134
Self-citationObesity-hypertension: an ongoing pandemic
Francischetti, E. A., & Genelhu, V. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01262.x · Cited by 157
Seckl, J. R., & Walker, B. R. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.09.007 · Cited by 154
Self-citationFactors affecting clinical assessment of insulin sensitivity in horses
Firshman, A. M., & Valberg, S. J. (2007) · Equine Veterinary Journal · doi:10.2746/042516407x238512 · Cited by 155
Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine.
Neeb, Z. P., Edwards, J. M., Alloosh, M., Long, X., Mokelke, E. A., & Sturek, M. S. (2010) · Europe PMC (PubMed Central) · Cited by 153
Clinical and laboratory diagnosis of the metabolic syndrome
Olufadi, R., & Byrne, C. D. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048363 · Cited by 124
Metabolic Syndrome in Cushing’s Syndrome
Chanson, P., & Salenave, S. (2010) · Neuroendocrinology · doi:10.1159/000314272 · Cited by 118
Keynote review: The adipocyte as a drug discovery target
Nawrocki, A. R., & Scherer, P. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03569-5 · Cited by 153
Cortisol Release From Adipose Tissue by 11β-Hydroxysteroid Dehydrogenase Type 1 in Humans
Stimson, R. H., Andersson, J., Andrew, R., Redhead, D. N., Karpe, F., Hayes, P. C., Olsson, T., & Walker, B. R. (2009) · Diabetes · doi:10.2337/db08-0969 · Cited by 128
“Transgenic overexpression of 11 -HSD1 in adipose tissue in mice results in a two- to threefold increase in portal vein glucocorticoid concentrations without altering systemic levels (9).”
BackgroundThe glucocorticoid contribution to obesity
Spencer, S. J., & Tilbrook, A. (2011) · Stress · doi:10.3109/10253890.2010.534831 · Cited by 127
11β‐HSD Type 1 Expression in Human Adipose Tissue: Impact of Gender, Obesity, and Fat Localization
Paulsen, S. K., Pedersen, S. B., Fisker, S., & Richelsen, B. (2007) · Obesity · doi:10.1038/oby.2007.233 · Cited by 136
“Studies of transgenic mice have shown that increased adipose 11 HSD1 expression induces complications similar to the metabolic syndrome (12,13).”
BackgroundBrain Adipocytokine Action and Metabolic Regulation
Ahima, R. S., Qi, Y., Singhal, N. S., Jackson, M. B., & Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-s018 · Cited by 150
Regulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue
Gathercole, L. L., Morgan, S. A., Bujalska, I. J., Hauton, D., Stewart, P. M., & Tomlinson, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026223 · Cited by 150
“In vitro, rodent and clinical data have endorsed 11b-HSD1 as a metabolic therapeutic target [39–41] and inhibitor studies including phase II studies in man are now published [13].”
BackgroundDeep Subcutaneous Adipose Tissue: A Distinct Abdominal Adipose Depot
Walker, G. E., Verti, B., Marzullo, P., Savia, G., Mencarelli, M., Zurleni, F., Liuzzi, A., & Di Blasio, A. M. (2007) · Obesity · doi:10.1038/oby.2007.231 · Cited by 127
“In addition, the selective overexpression of 11 -HSD1 in white adipose tissue of rodents results in central obesity, dyslipidemia, and insulin resistance, whereas homozygous knockout mice are protected from developing metabolic syndrome characteristics (18,47).”
BackgroundRole of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance
Asensio, C. S., Muzzin, P., & Rohner‐Jeanrenaud, F. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802856 · Cited by 150
Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action
Penning, T. M. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg022 · Cited by 140
Hydroxysteroid dehydrogenases (HSDs) in bacteria – A bioinformatic perspective
Kisiela, M., Skarka, A., Ebert, B., & Maser, E. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.08.002 · Cited by 148
DiNicolantonio, J. J., Mehta, V., Onkaramurthy, N. J., & O’Keefe, J. H. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.12.001 · Cited by 148
“Moreover, in adipocytes, 11β-HSD-1 gene expression is not only induced by TNF-alpha and IL-1(70,72,98) but also, correlates positively with adipocyte size.(97,99) However one study has found that 11β-HSD-1 expression is not increased in liver indicating tissuespecific differential regulation.”
InfluentialLeow, M. K., Addy, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021704 · Cited by 148
Wang, J., Sun, B., Hou, M., Pan, X., & Li, X. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.173 · Cited by 146
Nutritional manipulations in the perinatal period program adipose tissue in offspring
Lukaszewski, M.-A., Eberlé, D., Vieau, D., & Breton, C. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00231.2013 · Cited by 122
Pathogenesis of Type 2 Diabetes Mellitus
Al-Saraj, F. (2015) · InTech eBooks · doi:10.5772/59183 · Cited by 144
“This could have the same effect in human[46] suggesting that increases in endogenous 11β-HSD1 in the adipose tissue of obese humans and rodents [47,48] contribute to obesity-associated IR, in part due to increased delivery of glucocorticoids to the liver via the portal vein.”
BackgroundMetabolic control through glucocorticoid hormones: An update
Rose, A. J., & Herzig, S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.007 · Cited by 144
Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity
Schwartz, A., & Pashko, L. L. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2003.05.001 · Cited by 145
The metabolic abnormalities associated with non-alcoholic fatty liver disease
Haque, M., & Sanyal, A. J. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0325 · Cited by 143
From Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants
Pecoraro, N. C., Dallman, M. F., Warne, J. P., Ginsberg, A. B., Laugero, K. D., la Fleur, S. E., Houshyar, H., Gómez-Oliver, F., Bhargava, A., & Akana, S. F. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.004 · Cited by 144
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism
Marzolla, V., Armani, A., Zennaro, M., Cinti, F., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.011 · Cited by 143
“For example, adipose tissue-specific amplification of cortisol production in transgenicmice, via overexpression of the enzyme 11HSD1, which reactivates glucocorticoids from inactive 11keto forms, results in the typical phenotype of full metabolic syndrome, including central obesity, glucose intolerance, insulin resist…”
BackgroundGlucocorticoid Metabolism in Obesity and Following Weight Loss
Akalestou, E., Genser, L., & Rutter, G. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00059 · Cited by 143
“Mice overexpressing 11βHSD1 in adipose tissue develop visceral obesity, insulin resistance, dyslipidaemia, and hypertension (31), while liverspecific 11β-HSD1 overexpression results in insulin resistance and hypertension, but not obesity (32).”
BackgroundCortisol level dysregulation and its prevalence—Is it nature's alarm clock?
Jones, C., & Gwenin, C. D. (2020) · Physiological Reports · doi:10.14814/phy2.14644 · Cited by 141
“Obesity is characterized by visceral adipose tissue, which has high levels of glucocorticoid receptors (Musazaki et al., 2001).”
BackgroundRapid Hepatic Metabolism of 7-Ketocholesterol by 11β-Hydroxysteroid Dehydrogenase Type 1
Schweizer, R. A. S., Zürcher, M., Balazs, Z., Dick, B., & Odermatt, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313615200 · Cited by 130
11?-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
Stulnig, T. M., & Waldh�usl, W. (2004) · Diabetologia · doi:10.1007/s00125-003-1284-4 · Cited by 140
“Since GRα expression is markedly higher in visceral compared to subcutaneous adipose tissue [43], the differentiating effect of glucocorticoids is supposed to be more pronounced in visceral 4 T.”
BackgroundMethodInfluentialNon-carbohydrate Inhibitors of the Lectin DC-SIGN
Borrok, M. J., & Kiessling, L. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072944v · Cited by 140
Gougeon, M.-L., Pénicaud, L., Fromenty, B., Leclercq, P., Viard, J.-P., & Capeau, J. (2004) · Antiviral Therapy · doi:10.1177/135965350400900206 · Cited by 129
“When overexpressed in WAT in transgenic mice, a syndrome of visceral obesity with metabolic alterations was observed, close to the human metabolic syndrome [180].”
BackgroundCardiovascular risk associated with the metabolic syndrome
Lindsay, R. S., & Howard, B. V. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0013-9 · Cited by 139
“The potential metabolic importance of these observations is suggested by a recent animal model demonstrating artificially increasing 11-HSD1 activity in adipose tissue—by the introduction of an 11-HSD1 transgene under control of an adipose-specific promoter—results in the development of visceral adiposity, hyperglycem…”
BackgroundChapman, K. E., Coutinho, A. E., Zhang, Z., Kipari, T., Savill, J. S., & Seckl, J. R. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.002 · Cited by 120
Self-citationWang, L., Xu, N., Zhang, J., Zhao, H., Lin, L., Jia, S., & Jia, L. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.06.016 · Cited by 136
Adiponectin, obesity, and cardiovascular disease
Faßhauer, M., Paschke, R., & Stümvoll, M. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.016 · Cited by 136
Trayhurn, P. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004406 · Cited by 136
“…Y), surgically (lesions of the ventromedial hypothalamus), chemically (e.g. gold thioglucose administration) or through transgenics (e.g. uncoupling protein 1, 11b-hydroxysteroid dehydrogenase-1 and melanocortin-4 receptor knockouts; Lowell et al. 1993; Huszar et al. 1997; Masuzaki et al. 2001).”
BackgroundTop‐down and bottom‐up control of stress‐coping
de Kloet, E. R., de Kloet, S. F., de Kloet, C. S., & de Kloet, A. D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12675 · Cited by 135
Mitochondrial Dysfunction in Adipocytes as a Primary Cause of Adipose Tissue Inflammation
Woo, C.-Y., Jang, J. E., Lee, S. E., Koh, E. H., & Lee, K.-U. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0221 · Cited by 125
Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging
Wend, K., Wend, P., & Krum, S. A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00019 · Cited by 118
“Over-expression of HSD11B1 under the aP2 promoter resulted in a phenotype very similar to the metabolic syndrome (Masuzaki et al., 2001), whereas mice deficient for HSD11B1 are protected from this disease (Kotelevtsev et al., 1997; Morton et al., 2001).”
BackgroundGnanalingham, M. G., Mostyn, A., Symonds, M. E., & Stephenson, T. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00375.2005 · Cited by 119
“Furthermore, transgenic mice selectively overexpressing 11 HSD1 in adipose tissue develop visceral obesity and are glucose intolerant (32).”
Aoki, F., Honda, S., Kishida, H., Kitano, M., Naoki, A. R. A. I., Tanaka, H., Yokota, S., Nakagawa, K., Asakura, T., Nakai, Y., et al. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60463 · Cited by 134
Feng, Y., Huang, S., Dou, W., Zhang, S., Chen, J., Shen, Y., Shen, J., & Leng, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00826.x · Cited by 135
“, 2000), and overexpression of 11b-HSD1 selectively in adipose tissue causes hyperphagia (Masuzaki et al., 2001).”
BackgroundInfluentialHornby, C., Mollan, S. P., Botfield, H. F., O’Reilly, M., & Sinclair, A. J. (2018) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000684 · Cited by 131
“globally, or specifically in adipose tissue, have a metabolic syndrome phenotype of obesity, dyslipidemia, and glucose intolerance (28).”
BackgroundHoppmann, J., Perwitz, N., Meier, B., Fasshauer, M., Hadaschik, D., Lehnert, H., & Klein, J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0292 · Cited by 122
“Adipose tissue-specific amplification of glucocorticoids induces all the characteristic features of the metabolic syndrome (Masuzaki et al. 2001).”
BackgroundSteroid biosynthesis in adipose tissue
Li, J., Papadopoulos, V., & Vihma, V. (2015) · Steroids · doi:10.1016/j.steroids.2015.03.016 · Cited by 130
Psychosocial stress affects energy balance in mice: Modulation by social status
Moles, A., Bartolomucci, A., Garbugino, L., Conti, R., Caprioli, A., Coccurello, R., Rizzi, R., Ciani, B., & D'Amato, F. R. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.01.004 · Cited by 132
“Another possible explanation involves the activity of the enzyme 11-beta hydroxysteroid dehydrogenase type 1 (11-HSD-1) which converts the inactive 11-deydrocorticosterone into the active corticosterone, and which is locally high in the adipose tissue (Masuzaki et al., 2001).”
BackgroundObesity therapy: altering the energy intake-and-expenditure balance sheet
Crowley, V., Yeo, G. S. H., & O’Rahilly, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd770 · Cited by 128
“cgi?l=3290">HSD11B1 ) on the development of central obesity and its metabolic sequelae in mice indicate that this enzyme might be an interesting target for inhibition, particularly in human visceral obesit”
BackgroundMorton, N. M., Ramage, L., & Seckl, J. R. (2004) · Endocrinology · doi:10.1210/en.2003-1674 · Cited by 111
“We also measured 11 -HSD-1 activity in adipose depots from the C57BL/6JLep mice (5), as a comparator model of genetic obesity that shares the same genetic background (C57BL/6J) as the HF-induced obesity-susceptible mice in our study (Fig 2A).”
BackgroundMethodInfluentialSelf-citationScreening and diagnosis of Cushing’s syndrome
Findling, J. W., & Raff, H. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.02.001 · Cited by 127
“The importance of cortisol in the generation of abdominal obesity recently has been highlighted by targeted overexpression of 11bhydroxysteroid dehydrogenase type 1 in transgenic mice [26].”
Glucocorticoids and Metabolic Control
Magomedova, L., & Cummins, C. L. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_1 · Cited by 127
“Indeed, mice overexpressing 11β-HSD1 have higher intra-abdominal GC levels and exhibit central adipocyte hypertrophy (Masuzaki et al. 2001).”
BackgroundPereira, C., Azevedo, I., Monteiro, R., & Martins, M. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01582.x · Cited by 126
“Increased 11β-HSD1 activity in visceral adipose tissue may generate increased cortisol levels within adipose tissue and liver and, thereby, promote features of the metabolic syndrome [15,46].”
BackgroundResistin’s, obesity and insulin resistance: the continuing disconnect between rodents and humans
Huang, X., & Yang, Z. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0408-2 · Cited by 127
“Decreased mRNA expression in adipose tissue or isolated adipocytes—as opposed to the expected increased mRNA expression—has been reported in ob/ob, db/db, tub/tub, KKAy, and Zucker (fa/fa) genetic models of obesity [37, 47, 58, 61, 111].”
Backgroundβ-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action
Xiang, J. S., Ipek, M., Suri, V., Tam, M., Xing, Y., Huang, N., Zhang, Y., Tobin, J. F., Mansour, T. S., & McKew, J. C. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.035 · Cited by 126
Liver X Receptors Downregulate 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
Stulnig, T. M., Oppermann, U., Steffensen, K. R., Schuster, G. U., & Gustafsson, J.-A. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2426 · Cited by 115
“The pathophysiological consequences of such elevated 11 HSD-1 expression was recently demonstrated in mice selectively overexpressing 11 -HSD-1 in adipose tissue (6).”
BackgroundControl of body weight: a physiologic and transgenic perspective
Frühbeck, G., & Gómez‐Ambrosi, J. (2003) · Diabetologia · doi:10.1007/s00125-003-1053-4 · Cited by 125
“Evidence for this action is further provided by transgenic mice overexpressing 11β HSD-1 in adipose tissue, which have an increased adipose level of corticosterone, hyperlipidaemia, insulin resistance, hyperphagia despite hyperleptinaemia and visceral obesity [15].”
BackgroundGuo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 126
Liu, Y., Nakagawa, Y., Wang, Y., Sakurai, R., Tripathi, P. V., Lutfy, K., & Friedman, T. C. (2005) · Diabetes · doi:10.2337/diabetes.54.1.32 · Cited by 111
Nair, S., Lee, Y. H., Lindsay, R. S., Walker, B. R., Tataranni, P. A., Bogardus, C., Baier, L. J., & Permana, P. A. (2004) · Diabetologia · doi:10.1007/s00125-004-1407-6 · Cited by 124
“Transgenic mice overexpressing 11β-HSD1 in adipose tissue develop hyperphagia, visceral obesity, hyperglycaemia, hyperinsulinaemia, glucose intolerance, insulin resistance and hyperlipidaemia [13].”
Background11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
Wake, D. J., & Walker, B. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.015 · Cited by 124
Schuster, D., Maurer, E. M., Laggner, C., Nashev, L. G., Wilckens, T., Langer, T., & Odermatt, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600794 · Cited by 123
Staab-Weijnitz, C. A., & Maser, E. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.013 · Cited by 122
Holmes, M. C., Carter, R. N., Noble, J., Chitnis, S., Dutia, A., Paterson, J. M., Mullins, J. J., Seckl, J. R., & Yau, J. L. W. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0731-10.2010 · Cited by 103
“The rat 11 -HSD1 cDNA-based minigene, previously used to overexpress 11 -HSD1 in adipose tissue and liver (Masuzaki et al., 2001; Paterson et al., 2004), was fused in-frame at the C terminus to the influenza virus-derived hemagglutinin (HA) epitope tag by PCR-mediated, site-directed mutagenesis.”
InfluentialSelf-citationTargher, G., Bertolini, L., Rodella, S., Zoppini, G., Zenari, L., & Falezza, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02466.x · Cited by 111
Lindmark, S., Lönn, L., Wiklund, U., Tufvesson, M., Olsson, T., & Eriksson, J. W. (2005) · Obesity Research · doi:10.1038/oby.2005.81 · Cited by 113
Splanchnic Cortisol Production Occurs in Humans
Basu, R., Singh, R. J., Basu, A., Chittilapilly, E. G., Johnson, C. M., Toffolo, G., Cobelli, C., & Rizza, R. A. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2051 · Cited by 111
“3 becomes: (D3Ca D3Cv) (F01 F21)ttrD3 D3P (7) Eq.”
BackgroundInfluentialTiming of nutrient restriction and programming of fetal adipose tissue development
Symonds, M. E., Pearce, S., Bispham, J., Gardner, D. S., & Stephenson, T. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2004366 · Cited by 121
“Transgenic mice in which 11b-hydroxysteroid dehydrogenase type 1 is over expressed show substantially increased visceral adipose tissue deposition at 18 weeks of age (Masuzaki et al. 2001).”
BackgroundHackett, R. A., Kivimäki, M., Kumari, M., & Steptoe, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2853 · Cited by 121
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170009 · Cited by 86
Hardy, R. S., Filer, A., Cooper, M. S., Parsonage, G., Raza, K., Hardie, D. L., Rabbitt, E. H., Stewart, P. M., Buckley, C. D., & Hewison, M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1993 · Cited by 98
“Although 11β-HSD1 is classically associated with hepatic glucocorticoid responses, its effects on stromal cells appear to be equally important as exemplified by the recent characterization of the adipocyte-specific transgenic mouse for 11βHSD1, the phenotype of which is profound obesity [36].”
Social stress and recovery: implications for body weight and body composition
Tamashiro, K. L. K., Nguyen, M. M. N., Ostrander, M. M., Gardner, S. R., Ma, L. Y., Woods, S. C., & Sakai, R. R. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00371.2007 · Cited by 111
“Mice with adipocyte-specific overexpression of 11 -HSD1 have increased visceral adipose tissue and develop symptoms of the metabolic syndrome (33).”
Metadata
- Authors
- Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- Corresponding author
- Flier, Jeffrey S.
- Venue
- Science
- Published
- 2001-12-07
- Volume
- 294
- Issue
- 5549
- Pages
- 2166-2170
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2117268230
- Cited by
- 1,766
- References
- 34
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 30 · 2023: 19 · 2022: 23 · 2021: 44 · 2020: 34 · 2019: 39 · 2018: 54 · 2017: 52 · 2016: 63 · 2015: 74 · 2014: 72 · 2013: 106 · 2012: 98
- FWCI
- 71.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- visceral obesity, metabolic syndrome, 11β-hydroxysteroid dehydrogenase type 1, glucocorticoids, corticosterone, adipose tissue, transgenic mice, insulin resistance, diabetes mellitus, hyperlipidemia, hyperphagia, leptin, high-fat diet
- MeSH terms
- Abdomen, Adipose Tissue, Animals, Body Composition, Corticosterone, Dietary Fats, Disease Models, Animal, Eating, Humans, Hydroxysteroid Dehydrogenases, Hyperglycemia, Hyperinsulinism, Insulin Resistance, Lipids, Lipoprotein Lipase, Male, Mice, Transgenic, Obesity, Receptors, Glucocorticoid, Viscera, Weight Gain, Adipocytes, Gene Targeting, Leptin, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Cell Size, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.